Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US OptionsDetailed Quotes
NBIX250516C230000
- 0.00
- 0.000.00%
15min DelayClose Apr 30 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest230.00Strike Price0.00Turnover0.00%IV113.58%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma113.36Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Neurocrine Biosciences Newsroom
Oppenheimer Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $192
BofA Securities Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $179
CCORF Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $158
Neurocrine Price Target Cut to $158.00/Share From $163.00 by Canaccord Genuity
Neurocrine Is Maintained at Buy by Canaccord Genuity
Neurocrine Biosciences Analyst Ratings
Evercore Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $185
Evercore ISI Sticks to Their Buy Rating for Neurocrine (NBIX)
Evercore ISI Group Maintains Outperform on Neurocrine Biosciences, Lowers Price Target to $185
TD Cowen Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $165
Stifel Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $166
H.C. Wainwright Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $168
Neurocrine Is Maintained at Buy by HC Wainwright & Co.
Neurocrine Biosciences Analyst Ratings
BofA Securities Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $179
Bank of America Securities Sticks to Its Buy Rating for Neurocrine (NBIX)
Wedbush Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $115
Needham Upgrades Neurocrine Biosciences(NBIX.US) to Buy Rating, Announces Target Price $138
Neurocrine Biosciences Analyst Ratings
Neurocrine Price Target Announced at $138.00/Share by Needham
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
